Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PRESCOTT HEALTHCARE SOLUTIONS LLC

NPI: 1821454505 · PRESCOTT, AZ 86301 · Primary Care Clinic/Center · NPI assigned 01/11/2016

$13.24M
Total Medicaid Paid
418,643
Total Claims
366,004
Beneficiaries
150
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialO'NEIL, MICHAEL (CEO)
NPI Enumeration Date01/11/2016

Related Entities

Other providers sharing the same authorized official: O'NEIL, MICHAEL

ProviderCityStateTotal Paid
OLD PUEBLO HEALTHCARE LLC TUCSON AZ $3.86M
NASHOBA VISION ASSOCIATES INC GROTON MA $4K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 41,142 $1.32M
2019 50,315 $1.79M
2020 55,398 $1.30M
2021 47,152 $1.32M
2022 38,272 $1.27M
2023 87,491 $2.89M
2024 98,873 $3.35M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 143,747 123,671 $7.99M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 27,617 24,861 $1.10M
99401 27,523 24,374 $706K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 9,147 8,214 $410K
99215 Prolong outpt/office vis 4,184 3,773 $248K
99457 9,241 9,161 $229K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 2,720 2,624 $210K
95923 2,654 2,561 $210K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 2,821 2,712 $197K
96127 43,411 34,719 $156K
94060 4,166 3,868 $153K
95921 2,662 2,566 $145K
99454 4,396 4,356 $111K
93000 10,054 9,562 $104K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 1,184 1,156 $90K
99458 5,587 4,672 $87K
93922 1,542 1,500 $73K
99493 1,098 1,090 $66K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 4,562 3,590 $61K
94200 3,790 3,503 $58K
94690 1,606 1,521 $53K
93880 470 457 $49K
99385 606 579 $48K
99205 Prolong outpt/office vis 633 557 $46K
90460 Immunization administration through 18 years of age via any route, first or only component 855 836 $41K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 463 422 $35K
90792 Psychiatric diagnostic evaluation with medical services 325 299 $34K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 407 356 $33K
36415 Collection of venous blood by venipuncture 15,779 14,274 $32K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 1,004 905 $30K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 333 333 $29K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 584 572 $29K
93978 300 295 $28K
80050 General health panel 917 907 $28K
99490 Ccm add 20min 8,881 8,529 $26K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,881 1,486 $26K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 262 260 $23K
83036 Hemoglobin; glycosylated (A1C) 3,276 3,017 $22K
93925 139 136 $22K
99386 215 213 $22K
80061 Lipid panel 2,018 1,924 $20K
95806 129 122 $16K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 708 662 $12K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 120 118 $10K
93272 730 627 $10K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 170 160 $10K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 875 735 $9K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 692 650 $8K
99439 858 849 $8K
81025 1,156 1,034 $7K
81002 2,624 2,376 $6K
90756 326 296 $5K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 165 147 $4K
90688 371 310 $4K
99397 123 120 $4K
93356 175 172 $4K
82607 779 624 $3K
99497 208 201 $3K
87428 127 120 $3K
99453 250 235 $3K
80053 Comprehensive metabolic panel 519 451 $3K
96160 1,087 1,039 $2K
96116 94 79 $2K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 518 466 $2K
99491 Ccm add 20min 385 384 $1K
90791 Psychiatric diagnostic evaluation 13 12 $1K
96138 124 116 $1K
76700 Ultrasound, abdominal, real time with image documentation; complete 17 15 $1K
99443 17 15 $1K
96120 30 26 $925.92
84443 Thyroid stimulating hormone (TSH) 226 183 $787.71
84439 115 115 $722.78
80305 98 92 $715.76
99354 48 37 $655.19
76706 13 12 $650.34
99402 16 12 $640.00
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 41 25 $556.56
82043 117 112 $526.06
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 346 220 $426.73
99492 13 12 $417.69
99494 12 12 $320.95
90715 12 12 $315.75
82746 517 357 $305.57
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 91 82 $282.70
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit 128 127 $264.63
J1885 Injection, ketorolac tromethamine, per 15 mg 155 137 $216.03
11721 21 14 $176.39
83001 12 12 $160.35
83002 12 12 $159.79
99406 3,244 2,573 $134.65
99407 2,847 2,094 $125.44
36410 14 13 $119.31
94664 17 13 $113.67
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 481 368 $88.67
96119 16 15 $72.37
G0444 Annual depression screening, 5 to 15 minutes 2,640 2,142 $69.34
J0696 Injection, ceftriaxone sodium, per 250 mg 141 140 $64.91
G0442 Annual alcohol misuse screening, 5 to 15 minutes 1,840 1,474 $59.89
99173 100 88 $58.35
82570 15 15 $53.80
84481 39 39 $51.84
G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes 707 608 $45.19
G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) 46 39 $43.12
99408 1,898 1,516 $27.98
99473 17 15 $24.50
1160F 14,954 12,528 $18.82
96146 13 13 $18.48
G0506 Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) 59 51 $10.74
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 4,032 3,163 $3.16
J1100 Injection, dexamethasone sodium phosphate, 1 mg 14 13 $1.29
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 18 14 $1.20
1159F 13 13 $0.03
G8482 Influenza immunization administered or previously received 168 141 $0.00
4004F 2,153 1,855 $0.00
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 22 22 $0.00
96136 274 219 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 915 807 $0.00
G9621 Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling 33 24 $0.00
3078F 1,498 1,377 $0.00
90671 18 18 $0.00
G9451 Patient received one-time screening for hcv infection 324 268 $0.00
G8477 Most recent blood pressure has a systolic measurement of >= 140 mmhg and/or a diastolic measurement of >= 90 mmhg 330 293 $0.00
99072 156 137 $0.00
99409 406 270 $0.00
96130 72 66 $0.00
87652 24 12 $0.00
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 22 22 $0.00
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 14 14 $0.00
G8404 Lower extremity neurological exam performed and documented 18 16 $0.00
3050F 29 25 $0.00
1158F 12 12 $0.00
87400 34 15 $0.00
3079F 1,163 1,032 $0.00
2010F 2,594 2,324 $0.00
3074F 2,039 1,866 $0.00
G0432 Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening 592 440 $0.00
1125F 1,302 1,188 $0.00
3048F 597 493 $0.00
3049F 98 81 $0.00
1157F 12 12 $0.00
4450F 56 47 $0.00
3075F 783 695 $0.00
0001F 155 145 $0.00
3008F 931 786 $0.00
G9273 Blood pressure has a systolic value of < 140 and a diastolic value of < 90 37 34 $0.00
87486 22 22 $0.00
87581 22 22 $0.00
1000F 68 60 $0.00
G8419 Bmi documented outside normal parameters, no follow-up plan documented, no reason given 29 27 $0.00
1126F 13 13 $0.00